UK Markets closed

HCA Healthcare, Inc. (HCA)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
258.25+2.41 (+0.94%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 585.39B
Enterprise value 3112.56B
Trailing P/E 19.30
Forward P/E 114.66
PEG ratio (5-yr expected) 11.09
Price/sales (ttm)1.52
Price/book (mrq)348.99
Enterprise value/revenue 32.01
Enterprise value/EBITDA 79.29

Trading information

Stock price history

Beta (5Y monthly) 1.66
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3263.92
52-week low 3117.78
50-day moving average 3251.63
200-day moving average 3219.05

Share statistics

Avg vol (3-month) 31.38M
Avg vol (10-day) 31.96M
Shares outstanding 5330.66M
Implied shares outstanding 6N/A
Float 8245.81M
% held by insiders 122.47%
% held by institutions 173.87%
Shares short (29 Jul 2021) 43.58M
Short ratio (29 Jul 2021) 42.48
Short % of float (29 Jul 2021) 41.44%
Short % of shares outstanding (29 Jul 2021) 41.12%
Shares short (prior month 29 Jun 2021) 43.52M

Dividends & splits

Forward annual dividend rate 41.92
Forward annual dividend yield 40.77%
Trailing annual dividend rate 30.48
Trailing annual dividend yield 30.19%
5-year average dividend yield 4N/A
Payout ratio 46.58%
Dividend date 329 Sept 2021
Ex-dividend date 414 Sept 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin 8.87%
Operating margin (ttm)16.69%

Management effectiveness

Return on assets (ttm)12.06%
Return on equity (ttm)484.90%

Income statement

Revenue (ttm)56.02B
Revenue per share (ttm)166.80
Quarterly revenue growth (yoy)30.40%
Gross profit (ttm)19.23B
EBITDA 12.12B
Net income avi to common (ttm)4.97B
Diluted EPS (ttm)13.38
Quarterly earnings growth (yoy)34.40%

Balance sheet

Total cash (mrq)1.24B
Total cash per share (mrq)3.86
Total debt (mrq)34.37B
Total debt/equity (mrq)1,919.94
Current ratio (mrq)1.45
Book value per share (mrq)0.74

Cash flow statement

Operating cash flow (ttm)3.37B
Levered free cash flow (ttm)-898.5M